Company Filing History:
Years Active: 2016-2023
Title: Innovations of Jinling Zhang in Oximeter Technology
Introduction
Jinling Zhang is a notable inventor based in Qinhuangdao, China. He has made significant contributions to the field of medical technology, particularly in the development of oximeters. With a total of 5 patents to his name, his work has advanced the capabilities of devices used to measure blood oxygen levels.
Latest Patents
Zhang's latest patents include innovative designs for oximeters. One patent describes an oximeter that features a blood oxygen collecting unit with a first light emitting unit that emits red light and a second light emitting unit that emits infrared light. This device includes a light receiving sensor that captures the emitted light not absorbed by the human body and converts it into an electrical signal. Additionally, it has a storage unit for measurement data and a microprocessor that calculates blood oxygen saturation based on the detected signals. Another patent further enhances this technology by incorporating a judging unit that assesses whether the blood oxygen saturation falls below a specified threshold, along with a display unit for user feedback.
Career Highlights
Jinling Zhang is currently employed at Contec Medical Systems Co., Ltd., where he continues to innovate in the medical device sector. His work has been instrumental in improving the accuracy and functionality of oximeters, making them more reliable for clinical use.
Collaborations
Zhang collaborates with talented colleagues, including Kun Hu and Yunlong Xu, who contribute to the development of advanced medical technologies. Their teamwork fosters an environment of innovation and creativity, leading to groundbreaking advancements in their field.
Conclusion
Jinling Zhang's contributions to oximeter technology exemplify the impact of innovative thinking in medical devices. His patents reflect a commitment to enhancing healthcare through technology, ultimately benefiting patients and medical professionals alike.